CC BY 4.0 · Arq Neuropsiquiatr 2023; 81(S 01): S1-S96
DOI: 10.1055/s-0043-1774476
SCIENTIFIC WORK
Reabilitação
Code: PE218

Pharmacological management of chronic pain in children and adolescents with cerebral palsy and hip dislocation

Betânia Souza Oliveira
1   Hospital SARAH Brasília, Brasília DF, Brazil
,
Erica Ueno Imamura
1   Hospital SARAH Brasília, Brasília DF, Brazil
,
Eliana Valverde Magro Borigato
1   Hospital SARAH Brasília, Brasília DF, Brazil
,
Oton Naziazene Lima
1   Hospital SARAH Brasília, Brasília DF, Brazil
,
Clarissa Miranda Carneiro Albuquerque Olbertz
1   Hospital SARAH Brasília, Brasília DF, Brazil
,
Bruno Barbosa Oliveira Silva
1   Hospital SARAH Brasília, Brasília DF, Brazil
› Author Affiliations
 

    Background: Chronic pain is a common and significant issue in individuals with cerebral palsy, more frequent in those with greater neurological impairment, predominantly in the lower limbs, hip, and abdomen. Hip dislocation is one of the main causes of pain in this population, even in those submitted to orthopedic treatment, leading to difficulty in sleeping, eating, positioning, and daily care. The use of chronic pain medications in this context can assist in the management of these patients.

    Objective: To present the response to drug treatment for chronic hip pain in patients with cerebral palsy.

    Methods: Prospective study with evaluation of chronic hip pain complaints in patients with bilateral cerebral palsy starting from December 2020 at SARAH/Brasília Hospital. A pain scale (Pediatric Pain Profile – PPP) validated in Brazil for this population (Inventory of Pain Behavior in Neurological Disability-– ICDDN) was used and treatment with amitriptyline and/or gabapentin was instituted.

    Results: We followed 32 patients with bilateral cerebral palsy and chronic hip pain, 28 with hip dislocation, and four with subluxation, mean age of 14 years, 48% female. In the GMFCS (Gross Motor Function Classification System) classification two patients were level IV and 30 level V. Fourteen had undergone hip surgery (tenotomy, reconstruction surgery, or salvage surgery) and 15 had undergone one or more intra-articular injections (infiltration) with depomedrol and anesthetic associated with the anterior branch of the obturator nerve block for pain treatment but maintained this complaint. Amitriptyline was indicated for 22 patients, gabapentin for 19, with nine patients requiring a combination of both medications. All patients took the pain inventory (ICDDN) before and after the introduction of medication. Improvement of pain complaints was observed in 81% of patients. There was a significant reduction in pain scores (p < 0.0001). Persistent or recurrent pain was observed in six patients (19%), four of whom underwent hip infiltration and two reconstruction surgery. The mean follow-up was 12 months.

    Conclusions: The use of amitriptyline and/or gabapentin for the treatment of chronic hip pain in individuals with cerebral palsy resulted in better pain control, being a good coadjuvant therapeutic option in the follow-up of these patients.


    #

    No conflict of interest has been declared by the author(s).

    Publication History

    Article published online:
    18 September 2023

    © 2023. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

    Thieme Revinter Publicações Ltda.
    Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil